Association between antidepressants and venous thromboembolism in Taiwan

Journal of Clinical Psychopharmacology

Volumn 33, Issue 1, 2013, Pages 31-37

  Wu, Chi Shin ^a   Chang, Chia Ming ^b   Chen, Chuan Yu ^c,d   Wu, Erin Chia Hsuan ^e   Wu, Kuan Yi ^b   Liang, Hsin Yi ^b   Chao, Yu Lin ^f   Chung, Wen Shen Isabella ^a   Tsai, Hui Ju ^d,g  

^a FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^f TZU CHI UNIVERSITY   (Taiwan)

^g NORTHWESTERN UNIVERSITY   (United States)

Author keywords

antidepressant class; antidepressant use; potency; VTE

Indexed keywords

ANTIDEPRESSANT AGENT; SEROTONIN 2A ANTAGONIST; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AGED; ARTICLE; ASIAN; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; HEALTH CARE SYSTEM; HEALTH INSURANCE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TAIWAN; VENOUS THROMBOEMBOLISM;

ADOLESCENT; ADRENERGIC UPTAKE INHIBITORS; ADULT; AGE FACTORS; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; COMORBIDITY; DOPAMINE UPTAKE INHIBITORS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MONOAMINE OXIDASE INHIBITORS; ODDS RATIO; RECEPTOR, SEROTONIN, 5-HT2A; RISK ASSESSMENT; RISK FACTORS; SEROTONIN 5-HT2 RECEPTOR ANTAGONISTS; SEROTONIN UPTAKE INHIBITORS; SEX FACTORS; TAIWAN; TIME FACTORS; VENOUS THROMBOEMBOLISM; YOUNG ADULT;

EID: 84873082938     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0b013e3182777425     Document Type: Article

References (31)

1. Heit JA, Silverstein MD, Mohr DN, et al. Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study. Arch Intern Med. 1999;159:445-453.
2. Lee CH, Lin LJ, Cheng CL, et al. Incidence and cumulative recurrence rates of venous thromboembolism in the Taiwanese population. J Thromb Haemost. 2010;8:1515-1523.
3. Heit JA. The epidemiology of venous thromboembolism in the community. Arterioscler Thromb Vasc Biol. 2008;28:370-372.
4. Strudsholm U, Johannessen L, Foldager L, et al. Increased risk for pulmonary embolism in patients with bipolar disorder. Bipolar Disord. 2005;7:77-81.
5. Maly R, Masopust J, Hosak L, et al. Assessment of risk of venous thromboembolism and its possible prevention in psychiatric patients. Psychiatry Clin Neurosci. 2008;62:3-8.
6. Thomassen R, Vandenbroucke JP, Rosendaal FR. Antipsychotic medication and venous thrombosis. Br J Psychiatry. 2001;179:63-66.
7. Vandenbroucke JP, Bertina RM, Holmes ZR, et al. Factor V Leiden and fatal pulmonary embolism. Thromb Haemost. 1998;79:511-516.
8. Parkin L, Skegg DC, Herbison GP, et al. Psychotropic drugs and fatal pulmonary embolism. Pharmacoepidemiol Drug Saf. 2003;12:647-652.
9. Ray JG, Mamdani MM, Yeo EL. Antipsychotic and antidepressant drug use in the elderly and the risk of venous thromboembolism. Thromb Haemost. 2002;88:205-209.
10. Zornberg GL, Jick H. Antipsychotic drug use and risk of first-time idiopathic venous thromboembolism: a case-control study. Lancet. 2000;356:1219-1223.
11. Kurne A, Ertugrul A, Anil Yagcioglu AE, et al. Venous thromboembolism and escitalopram. Gen Hosp Psychiatry. 2004;26:481-483.
12. Arnone D, Hansen L, Davies G. Pulmonary embolism and severe depression. Am J Psychiatry. 2002;159:873-874.
13. Pantel J, Schroder J, Eysenbach K, et al. Two cases of deep vein thrombosis associated with a combined paroxetine and zotepine therapy. Pharmacopsychiatry. 1997;30:109-111.
14. Jick SS, Li L. Antidepressant drug use and risk of venous thromboembolism. Pharmacotherapy. 2008;28:144-150.
15. Lacut K, Le Gal G, Couturaud F, et al. Association between antipsychotic drugs, antidepressant drugs and venous thromboembolism: results from the EDITH case-control study. Fundam Clin Pharmacol. 2007;21:643-650.
16. Klatsky AL, Armstrong MA, Poggi J. Risk of pulmonary embolism and/or deep venous thrombosis in Asian-Americans. Am J Cardiol. 2000;85:1334-1337.
17. Chen Y, Guo JJ, Li H, et al. Risk of cerebrovascular events associated with antidepressant use in patients with depression: a population-based, nested case-control study. Ann Pharmacother. 2008;42:177-184.
18. Wu CS, Wang SC, Cheng YC, et al. Association of cerebrovascular events with antidepressant use: a case-crossover study. Am J Psychiatry. 2011;168:511-521.
19. Meijer WE, Heerdink ER, Nolen WA, et al. Association of risk of abnormal bleeding with degree of serotonin reuptake inhibition by antidepressants. Arch Intern Med. 2004;164:2367-2370.
20. Wu CS, Ting TT, Wang SC, et al. Effect of benzodiazepine discontinuation on dementia risk. Am J Geriatr Psychiatry. 2011;19:151-159.
21. The Longitudinal Health Insurance Database. Available at: http://w3.nhri.org.tw/nhird/date-cohort.htm#1. Accessed December 8, 2011.
22. World Health Organization, Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC Classification and DDD Assignment. Oslo, WHO, 2009.
23. Richelson E. Pharmacology of antidepressants. Mayo Clin Proc. 2001;76:511-527.
24. Tatsumi M, Groshan K, Blakely RD, et al. Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol. 1997;340:249-258.
25. Vaishnavi SN, Nemeroff CB, Plott SJ, et al. Milnacipran: a comparative analysis of human monoamine uptake and transporter binding affinity. Biol Psychiatry. 2004;55:320-322.
26. Arbogast PG, Ray WA. Use of disease risk scores in pharmacoepidemiologic studies. Stat Methods Med Res. 2009;18:67-80.
27. Miettinen OS. Stratification by a multivariate confounder score. Am J Epidemiol. 1976;104:609-620.
28. Sauer WH, Berlin JA, Kimmel SE. Selective serotonin reuptake inhibitors and myocardial infarction. Circulation. 2001;104:1894-1898.
29. Musselman DL, Tomer A, Manatunga AK, et al. Exaggerated platelet reactivity in major depression. Am J Psychiatry. 1996;153:1313-1317.
30. Biegon A, Essar N, Israeli M, et al. Serotonin 5-HT2 receptor binding on blood platelets as a state dependent marker in major affective disorder. Psychopharmacology (Berl). 1990;102:73-75.
31. Birman-Deych E, Waterman AD, Yan Y, et al. Accuracy of ICD-9-CM codes for identifying cardiovascular and stroke risk factors. Med Care. 2005;43:480-485.